Kulukian Anita, Han Joo Seok, Cleveland Don W
Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093, USA.
Dev Cell. 2009 Jan;16(1):105-17. doi: 10.1016/j.devcel.2008.11.005.
Premature anaphase onset is prevented by the mitotic checkpoint through production of a "wait anaphase" inhibitor(s) that blocks recognition of cyclin B and securin by Cdc20-activated APC/C, an E3 ubiquitin ligase that targets them for destruction. Using physiologically relevant levels of Mad2, Bub3, BubR1, and Cdc20, we demonstrate that unattached kinetochores on purified chromosomes catalytically generate a diffusible Cdc20 inhibitor or inhibit Cdc20 already bound to APC/C. Furthermore, the chromosome-produced inhibitor requires both recruitment of Mad2 by Mad1 that is stably bound at unattached kinetochores and dimerization-competent Mad2. We show that purified chromosomes promote BubR1 binding to APC/C-Cdc20 by acting directly on Mad2, but not BubR1. Our results support a model in which immobilized Mad1/Mad2 at kinetochores provides a template for initial assembly of Mad2 bound to Cdc20 that is then converted to a final mitotic checkpoint inhibitor with Cdc20 bound to BubR1.
有丝分裂检查点通过产生一种“等待后期”抑制剂来防止后期过早开始,这种抑制剂会阻止细胞周期蛋白B和分离酶被Cdc20激活的后期促进复合物/细胞周期体(APC/C)识别,APC/C是一种E3泛素连接酶,会将它们靶向降解。利用生理相关水平的Mad2、Bub3、BubR1和Cdc20,我们证明纯化染色体上未附着的动粒催化产生一种可扩散的Cdc20抑制剂,或抑制已与APC/C结合的Cdc20。此外,染色体产生的抑制剂既需要稳定结合在未附着动粒上的Mad1招募Mad2,也需要具备二聚化能力的Mad2。我们表明,纯化的染色体通过直接作用于Mad2而非BubR1来促进BubR1与APC/C-Cdc20结合。我们的结果支持这样一种模型,即动粒上固定的Mad1/Mad2为与Cdc20结合且随后转化为最终有丝分裂检查点抑制剂(Cdc20与BubR1结合)的Mad2的初始组装提供了模板。